超微脑得健对脑缺血后神经再生相关信号GAP-43、Rho蛋白的影响
|
摘要
目的：探讨超微脑得健对脑缺血大鼠脑内神经再生相关信号GAP-43、Rho的影响,揭示其可能分子机制。
方法：
1.通过古代和现代文献整理,复习缺血性脑血管疾病的中西医认识和防治进展。学习经典补阳还五汤的现代药理作用。初步认识一些调节中枢神经再生的信号分子。
2.采用MCAO法复制大鼠局灶性脑缺血模型,将140只成年SD雄性大鼠随机分为空白对照组(即正常组)、假手术组、模型组、补阳还五汤组、脑得健原方组,超微脑得健全量组,超微脑得健1/3剂量组。分别给予不同处理,在1d、3d、7d、14d不同时间点处死动物,TTC染色法观察大鼠脑梗死情况并进行神经功能评分,采用免疫组化、RT-PCR法检测超微脑得健对GAP-43、Rho蛋白表达的影响。
结果：
1.文献研究缺血性脑血管疾病是中老年常见疾病。
1.1中医常见气虚血瘀型,气虚是本,血瘀为标；常用益气活血、祛瘀生新法治疗。
1.2西医多见血栓型,多以物质堵塞腔管,血液流变学障碍为表现。现代西医认为促进中枢神经再生为脑缺血后主要治疗目标。多种内外科治疗效果不佳或存在明显使用缺陷。
1.3补阳还五汤具多种现代药理学作用从而促进脑缺血后神经功能恢复。
1.4 GAP-43是目前国际公认的促中枢神经元再生的标记性蛋白,小G蛋白Rho则为新近的抑制中枢神经再生分子信号之一
2实验研究
2.1.TTC法检测造模成功的大鼠脑组织梗死面积大于健侧,呈苍白梗死灶。
2.2脑得健干预的各实验组脑组织病理切片呈好转状态。
2.3给药3天后,脑得健干预组各时间点神经功能积分均显著低于模型组(P<0.05),超微脑得健1/3剂量组各时间点神经功能积分和补阳还五汤及脑得健各组比(P>0.05)。
2.4免疫组化结果示各治疗组GAP-43表达水平在各时间点均高于对照组,两者之间差异有统计学意义(P<0.05)
2.5给药3d后各治疗组动物脑组织中GAP-43 mRNA含量较同时段模型组比较明显增加(p<0.05),脑得健方组和补阳还五汤组比较差异无统计学意义(p>0.05),各药物组比较差异无统计学意义(p>0.05)。
2.6给药3d后各治疗组动物脑组织中Rho mRNA含量较同时段模型组比较明显降低(p<0.05),脑得健方各组和补阳还五汤组比较差异无统计学意义(p>0.05)。
结论:
1脑得健方能改善大鼠局灶性脑缺血神经功能缺失症状。
2脑得健能促进MCAO大鼠脑缺血损伤后GAP43蛋白表达同时抑制Rho蛋白表达。可能是其促脑缺血后神经再生和功能恢复的治疗机制之一。
3超微脑得健1/3剂量和传统脑得健饮片以及传统补阳还五汤作用相当。
Objectives:Study on the effect of UNDJ on neural regeneration signaling molecule GAP-43、Rho during cerebral infarction convalescence to provide the possible anti-ischemic mechanism.
Methods:
1. Through the collection of ancient and modern literature, review the process of prevention and treatment on ICVD both in Western and Chinese medicine. Study the modern pharmacological action of classical decoction Buyang Huanwu. Have a preliminary grasp of some signaling molecules on neural regeneration.
2. Rat focal cerebral ischemia was induced by MCAO, After Rats model of focal cerebral ischemia induced, All adult male SD rats were randomly divided into 7 groups including naive, shame-operated, ischemic, ischemic with BYHW, ischemic with NDJ, ischemic with UNDJ and ischemic with 1/3UNDJ groups. Each group have 20 rats. ALL the rats were given different treatment and were killed in 1,3,7or14day after operation. To observe the infarct size by TTC and evaluation the nerve function, the expressions of GAP-43、Rho were measured by immunohistochemical staining both with RT-PCR.
Results:
1. Literature Study:ICVD is a common complaint among the elderly.
1.1 Pattern of qi deficiency and blood stasis is often seen in traditional Chinese medical science, qi deficiency is etiological factor while blood stasis is symptomatic factor. We replenishing qi and activating blood in order to dispelling stasis to promote regeneration.
1.2 Cerebral thrombosis is often seen in western medicine, Obstruction of a blood vessel and hemorheology by an embolus usually can be seen. Modern medicine shows that the main therapeutic goal during cerebral infarction convalescence is to help the centrum neural regeneration.But now all the treatment effects are have deficient and below the mark.
1.3 BYHW have many modern pharmacological action to improve the neurological deficit.
1.4 GAP-43 is a internationally recognized neural regeneration signaling protein,and small G-protein Rho is one of the latest rejection capability neural regeneration signaling molecule.
2. Experimental Study:
2.1 After ischemia, the pale infarction in hemorrhage brain can be seem greater than the brain offside by TTC detection。
2.2 All the pathological sections with NDJ treatment groups show a improved tendency.
2.3 All the NDJ treatment groups can significant improve neurological deficits at 3,7,14days (P< 0.05), the 1/3UNDJ group,BYHW group and decoction NDJ group have no obvious differences at each time point (P>0.05)
2.4 Immunohistochemical staining showed that the GAP-43 expressions level in all treatment groups is higher than the ischemic groups at each time point, there was a significant difference(P<0.05).
2.5 RT-PCR showed that the GAP-43 mRNA level in all treatment groups is higher than the ischemic groups after 3d time point, there was a significant difference(P<0.05). the 1/3UNDJ group,BYHW group and decoction NDJ group have no obvious differences at each time point (P>0.05)
2.6 RT-PCR showed that the Rho mRNA level in all treatment groups is lower than the ischemic groups after 3d time point, there was a significant difference(P<0.05). the 1/3UNDJ group,BYHW group and decoction NDJ group have no obvious differences at each time point (P>0.05)
Conclusions:
1. Decoction NDJ can improve the neurological deficits.
2. NDJ can promote GAP43 expression while resistant Rho expression after cerebral ischemia of MCAO rats,which maybe one of anti-ischemic mechanism of the drug.
3.1/3 UNDJ is affected with a considerable amount of the role of traditional pieces.
方法：
1.通过古代和现代文献整理,复习缺血性脑血管疾病的中西医认识和防治进展。学习经典补阳还五汤的现代药理作用。初步认识一些调节中枢神经再生的信号分子。
2.采用MCAO法复制大鼠局灶性脑缺血模型,将140只成年SD雄性大鼠随机分为空白对照组(即正常组)、假手术组、模型组、补阳还五汤组、脑得健原方组,超微脑得健全量组,超微脑得健1/3剂量组。分别给予不同处理,在1d、3d、7d、14d不同时间点处死动物,TTC染色法观察大鼠脑梗死情况并进行神经功能评分,采用免疫组化、RT-PCR法检测超微脑得健对GAP-43、Rho蛋白表达的影响。
结果：
1.文献研究缺血性脑血管疾病是中老年常见疾病。
1.1中医常见气虚血瘀型,气虚是本,血瘀为标；常用益气活血、祛瘀生新法治疗。
1.2西医多见血栓型,多以物质堵塞腔管,血液流变学障碍为表现。现代西医认为促进中枢神经再生为脑缺血后主要治疗目标。多种内外科治疗效果不佳或存在明显使用缺陷。
1.3补阳还五汤具多种现代药理学作用从而促进脑缺血后神经功能恢复。
1.4 GAP-43是目前国际公认的促中枢神经元再生的标记性蛋白,小G蛋白Rho则为新近的抑制中枢神经再生分子信号之一
2实验研究
2.1.TTC法检测造模成功的大鼠脑组织梗死面积大于健侧,呈苍白梗死灶。
2.2脑得健干预的各实验组脑组织病理切片呈好转状态。
2.3给药3天后,脑得健干预组各时间点神经功能积分均显著低于模型组(P<0.05),超微脑得健1/3剂量组各时间点神经功能积分和补阳还五汤及脑得健各组比(P>0.05)。
2.4免疫组化结果示各治疗组GAP-43表达水平在各时间点均高于对照组,两者之间差异有统计学意义(P<0.05)
2.5给药3d后各治疗组动物脑组织中GAP-43 mRNA含量较同时段模型组比较明显增加(p<0.05),脑得健方组和补阳还五汤组比较差异无统计学意义(p>0.05),各药物组比较差异无统计学意义(p>0.05)。
2.6给药3d后各治疗组动物脑组织中Rho mRNA含量较同时段模型组比较明显降低(p<0.05),脑得健方各组和补阳还五汤组比较差异无统计学意义(p>0.05)。
结论:
1脑得健方能改善大鼠局灶性脑缺血神经功能缺失症状。
2脑得健能促进MCAO大鼠脑缺血损伤后GAP43蛋白表达同时抑制Rho蛋白表达。可能是其促脑缺血后神经再生和功能恢复的治疗机制之一。
3超微脑得健1/3剂量和传统脑得健饮片以及传统补阳还五汤作用相当。
Objectives:Study on the effect of UNDJ on neural regeneration signaling molecule GAP-43、Rho during cerebral infarction convalescence to provide the possible anti-ischemic mechanism.
Methods:
1. Through the collection of ancient and modern literature, review the process of prevention and treatment on ICVD both in Western and Chinese medicine. Study the modern pharmacological action of classical decoction Buyang Huanwu. Have a preliminary grasp of some signaling molecules on neural regeneration.
2. Rat focal cerebral ischemia was induced by MCAO, After Rats model of focal cerebral ischemia induced, All adult male SD rats were randomly divided into 7 groups including naive, shame-operated, ischemic, ischemic with BYHW, ischemic with NDJ, ischemic with UNDJ and ischemic with 1/3UNDJ groups. Each group have 20 rats. ALL the rats were given different treatment and were killed in 1,3,7or14day after operation. To observe the infarct size by TTC and evaluation the nerve function, the expressions of GAP-43、Rho were measured by immunohistochemical staining both with RT-PCR.
Results:
1. Literature Study:ICVD is a common complaint among the elderly.
1.1 Pattern of qi deficiency and blood stasis is often seen in traditional Chinese medical science, qi deficiency is etiological factor while blood stasis is symptomatic factor. We replenishing qi and activating blood in order to dispelling stasis to promote regeneration.
1.2 Cerebral thrombosis is often seen in western medicine, Obstruction of a blood vessel and hemorheology by an embolus usually can be seen. Modern medicine shows that the main therapeutic goal during cerebral infarction convalescence is to help the centrum neural regeneration.But now all the treatment effects are have deficient and below the mark.
1.3 BYHW have many modern pharmacological action to improve the neurological deficit.
1.4 GAP-43 is a internationally recognized neural regeneration signaling protein,and small G-protein Rho is one of the latest rejection capability neural regeneration signaling molecule.
2. Experimental Study:
2.1 After ischemia, the pale infarction in hemorrhage brain can be seem greater than the brain offside by TTC detection。
2.2 All the pathological sections with NDJ treatment groups show a improved tendency.
2.3 All the NDJ treatment groups can significant improve neurological deficits at 3,7,14days (P< 0.05), the 1/3UNDJ group,BYHW group and decoction NDJ group have no obvious differences at each time point (P>0.05)
2.4 Immunohistochemical staining showed that the GAP-43 expressions level in all treatment groups is higher than the ischemic groups at each time point, there was a significant difference(P<0.05).
2.5 RT-PCR showed that the GAP-43 mRNA level in all treatment groups is higher than the ischemic groups after 3d time point, there was a significant difference(P<0.05). the 1/3UNDJ group,BYHW group and decoction NDJ group have no obvious differences at each time point (P>0.05)
2.6 RT-PCR showed that the Rho mRNA level in all treatment groups is lower than the ischemic groups after 3d time point, there was a significant difference(P<0.05). the 1/3UNDJ group,BYHW group and decoction NDJ group have no obvious differences at each time point (P>0.05)
Conclusions:
1. Decoction NDJ can improve the neurological deficits.
2. NDJ can promote GAP43 expression while resistant Rho expression after cerebral ischemia of MCAO rats,which maybe one of anti-ischemic mechanism of the drug.
3.1/3 UNDJ is affected with a considerable amount of the role of traditional pieces.
引文
[1]常富业,王永炎.中风病发病学研究述评[J].辽宁中医杂志2004,31(2)：102-103.
[2]Sacco RL,el al.Vascular disease.In:Merritt's textbook of neurology, 10th edition,2000,217-274
[3]李菁.缺血性脑血管病神经保护治疗的研究进展[J].药物临床治疗杂志,2005,3(6)：16-20.
[4]Taupin P, Gage FH. Adult neurogenesis and neural stem cells of the central nervous system in mammals[J].Neurosci Res,2002,69:745.
[5]Fred H. Gage. Ma mmalian Neural stm cells[J]. Curt opin genet dev, 2003,13(5):543-550.
[6]Albers GW,Hart R,Lutse PHL,et al.Supplement to the guidelines for the management of transient ischemic attacks. [J].Stroke,2000,30: 2502-2511
[7]金惠铭,王建枝.病理生理学[M].人民卫生出版社,第7版,2008,1：271-272
[8]Thrift A G. Cholesterol is associated with stroke, but is not a risk factor[J].Stroke,2004,(35):1524-15257.
[9]Matsuda S, Umeda M, Uchida H, el al.Alterations of oxidative stress markers and apoptosis markers in the striatum after transient focal cerebral ischemia in rats. [J].Neural Transm.2009 Apr,116(4):395-404.
[10]Dowlatshahi D, Hakim A, Fang J, el al.Pre admission antithrombo-tics are associated with improved outcomes following ischaemic stroke:a cohort from the Registry of the Canadian Stroke Network[J].Stroke.2009 Oct;4(5):328-34.
[11]Labarthe DR, Dai S, Fulton JE, el al. Systolic and fourth- and fifth-phase diastolic blood pressure from ages 8 to 18 years:Project HeartBeat! [J]. Prev Med.2009 Jul;37(1 Suppl):S86-96.
[12]Koh-Tan HH, Graham D, Hamilton CA, el al. Renal and vascular glutathioneS-transferase mu is not affected by pharmacological intervention to reduce systolic blood pressure. [J]. Hypertens.2009, Aug;27(8):1575-84.
[13]Kleinig TJ, Kimber TE, Thompson PD. Stroke prevention and stroke thrombolysis:quantifying the potential benefits of best practice therapies[J].Med J Aust.2009, Jun 15,190(12):678-82.
[14]Nakatomi H, Kuriu T, Okabe S, el al. Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. [J].Cell 2002; 110:429-441.
[15]Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke:an integrated view. [J]. Trends Neurosci,1999,22:391-397.
[16]霍玉书,霍虹.鹿茸神经因子活性及促分化作用研究[J].中药新药与临床药理,1997,8(2)：79.
[17]Garofalo L, Silva ABD, Cuello AC.Nerve growth factor-induced synap-togenesis and hypertrophy of cortical cholinergic terminals. Proc Natl A-cad Sci USA,1992,89:2639-2643.
[18]洪新如,陈新民,卢晓欣.不同时间脑室注射脑源性神经营养因子治疗新生大鼠缺氧缺血性脑损伤效果的比较[J].中国药理学通报2002,18(2)：204-207
[19]Veizovic T,Beech JS,Stromer R,et al.Resolution of stroke defi-cits following con-tralateral grafts of conditionally immortal neuroepl-thelial stem cells[J].Stroke.2001,32(4):1012-1019.
[20]Toda H.Takahashi J,lwakami N,et al.Grafting neural stem ceils improved the impaired spatial recognition in ischemic rats[J]. Neu-rosei ett.2001,316(1):9-12.
[21]Aguirre A, Rizvi TA, Ratner N, et al. Over expression ofEGF receptor con-feres migratory properties to non-migratory post natal neural progenitors [J]. Neurosci.2005,25:11092.
[22]Chu K, Kin M, Park KI, et al. Human neural stem cells improve sensorimotor deficits in the adult rat brain with experimental focal ischemia[J].Brain Res,2004,1016:145-153.
[23]唐映红,梁燕,等.补阳还五汤及其有效组分生物碱和苷对动脉血栓形成大鼠抗凝系统活性的影响[J].中国实验方剂学杂志,2007,13(6)：39-42.
[24]曲宏达,佟丽,沈剑刚.等.补阳还五汤对体外培养的大鼠皮层神经 元缺氧凋亡的影响[J].第一军医大学学报,2002,22(1)：35-38.
[25]宋含平,刘志龙,邓常青.补阳还五汤对沙鼠脑缺血后海马CA1区细胞形态结构与细胞凋亡的影响[J].中国中医药信息杂志,2004,8：682.
[26]唐映红,李花,等.补阳还五汤有效部位对局灶性脑缺血再灌注后caspase表达的作用[J].中国中西医结合杂志.2006,26(6)：533-537
[27]蔡光先,刘柏炎.阳还五汤对体外低糖低氧损伤海马神经干细胞增殖的影响[J].湖南中医学院学报,2005,25(2)：1-3
[28]刘柏炎,蔡光先,等.补阳还五汤对大鼠局灶性脑缺血后神经干细胞影响的初步研究[J].中国临床康复.2004,8(22)：4532-4533
[29]刘柏炎,蔡光先,等.补阳还五汤对低糖低氧损伤神经干细胞移行分化的影响[J],中国药物与临床.2005,5(3)：171-173
[30]张运克,车志英.益气活血方体外诱导大鼠骨髓间充质干细胞向神经细胞的分化[J].中国组织工程研究与临床康复,2009,13(6)：1171-1175
[31]刘芳,白雪松,刘柏炎,等.补阳还五汤对脑缺血大鼠碱性成纤维细胞生长因子的影响[J],中国中西医结合急救杂志.2008,15(1)：9-12
[32]尹天雷,蔡光先,等.补阳还五汤对脑缺血模型大鼠脑组织NGF及P13 K/AKT信号转导途径的影响[J].中国中医药科技.2008,15(1)：24-25
[33]刘柏炎,沈剑刚,蔡光先,等.补阳还五汤对局灶性脑缺血大鼠脑内caveolinl.2的影响[J].湖南中医药大学学报,2008,28(1)：22-28
[34]Chen Y, Sun FY. Age-related decrease of striatal neurogenesis is associated with apoptosis of neural precursors and newborn neurons in rat brain after ischemia. [J].Brain Res.2007 Jul 7;
[35]Gold B G. FK506 and the role of the immunophilin FKBP-52 in nerve regeneration [J].Drug Mestabol Rev.1999,31:649-663.
[36]Wang M S, Gold B G.FK506 increases the regeneration of spinal cord axons in a predegenerated peripheral nerve autograft [J].Spinal Cord Med.1999,22(4):287-296.
[37]Lee M. Doolabh V B. Mackinnen S E. et al FK506 promotes functional reeovery in crushed rat sciatic nerve Muscle [J].Nerve. 2000.23(4):633-640.
[38]崔瑾等.急性脑缺血大鼠海马和齿状回神经元β-NGF与NGFRs基因表达变化对其生存影响的研究[J].现代神经疾病杂志2003,3(3)：137-141
[39]田京发,刘达根,付小兵.碱性成纤维细胞生长因子的药代动力学研究进展[J].中国危重病急救医学,2000,12(8)：509—510
[40]Yao H, Takasawa R, Fukuda K, et al. DNA fragmentation in ischemic core and penumbra in focal cerebral ischemia in rats. [J].Brain Res gol Brain Res 2001; 91(1-2):112-118.
[41]Rao RV, Hermel E, Castro Obregon S, et al. Coupling end—plasmic reticulum stress to the cell death program. Mechanism of caspase activation. [J]. Biol Chem 2001; 276(36):33869-33874.
[42]McManus Jp, Buchan AM. Apoptosis after experimental stroke: faCt or fashion? [J].Neurotrauma 2000,17(10):899-914.
[43]Davoli MA, Fourtounis J, Tam J, el al.Immunohistochemical and biochemical assessment of caspase 3 activation andDNA fragmenta-tion following transient focal ischemia in the rat[J].Neuroscience 2002,115(1):125-136.
[44]韩彩萍.PI3K/AKT信号通路与脑缺血神经细胞凋亡[J].国际神经病学神经外科学杂志,2006,33(1)
[45]曲鹏等.凋亡相关基因与脑缺血再灌注损伤[J].解剖科学进展,2006,12(1)：52-56
[46]汪咏莳,周国民.中枢神经系统microRNA的研究进展[J].解剖学杂志.2009,32(3)：410-412
[47][J].生物学教学,2009,34(4)：76
[48]Nadeau S, Hein P, Fernandes K J, et al. A transcrip tional role for C/EBP beta in the neuronal response to axonal injury [J]. Mol CellNeu2rosci,2005,29 (4):525-535.
[49]Becker T, Lieberoth B C, Becker C G, et al. Differences in the regen-erative response of neuronal cell populations and indications for p lasticity in intrasp inal neurons after sp inal cord transection in adult zebrafish [J]. Mol Cell Neurosci,2005,30 (2):265-278.
[50]Li Y, Chen J, Zhang C L, et al. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells [J].Glia, 2005,49(3):407-417.
[51]Ollom CM, Denny JB. A Crosslinking Analysis of GAP-43 Interactions with Other Proteins in Differentiated N1E-115 Cells. [J].Mol Sci.2008,9(9):1753-71.
[52]Nguyen L, He Q, Meiri KF. Regulation of GAP-43 at serine 41 acts as a switch to modulate both intrinsic and extrinsic. behaviors of growing neurons, via altered membrane distribution. [J]. Mol Cell Neurosci.2009 May; 41(1):62-73.
[53]严恒林.生长相关蛋白(GAP-43)与神经发育和再生[J].神经解剖学杂志,1993,9(2)：1551
[54]Ludwig A, Silvia A, Josef PK, el al.Overexp ression of the neural growth-associated protein GAP-43 induces nerve sp routing in the adult nervoussystem of transgenic mice[J].Cell,1995; 83:2691
[55]吕刚等.神经干细胞分化过程中GAP-43基因的表达及其意义[J].中国医科大学学报.2007,36(1)：47-48
[56]赵惠等.8溴-环磷酸腺苷对脑缺血再灌注大鼠PKA及GAP-43蛋白表达的影响[J].脑与神经疾病杂志.2007,15(2)：101-103
[57]Luque JM, Puign N,Martinez JM, el al.Glutamate Nmethy LDaspar- tate recep tor blockade prevents induction of GAP-43 after focal ischemiain rats[J].1Neurosci Lett,2001; 305 (2):87-91
[58]Bustelo XR, Sauzeau V, Berenjeno IM. GTP-binding p roteins of the Rho/Rac family:regulation,effectors and functions in vivo. [J].Bioessays,2007,29(4):356-370
[59]Piekny A, Werner M,Glotze M. Cytokinesis:welcome to the Rho zone [J]. Trends Cell Biol,2005,15 (12):651-658.
[60]Etienne2Manneville S,Hall A. Rho GTPases in cell biology[J]. Nature,2002,420:629-635.
[61]Teng F Y, TangB L. Why do Nogo/Nogo-66 recep tor gene knockouts result in inferior regeneration compared to treatment with neutralizing agents? [J].J Neurochem,2005,94 (4):865-874.
[62]Petratos S, Li QX, George AJ, el al. The beta-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism. [J].Brain.2008 Jan;131(Pt 1):90-108.
[63]陈胜利,李长清.RhoA与神经轴突的生长[J].实用神经疾病杂.2005,8(3)：36-37
[64]李德渊,陈娟,等.脑白质损伤新生大鼠脑白质P75NTR蛋白与RhoA mRNA的表达及意义[J].中国当代儿科杂志.2007,9(4)：317-320
[65]Schimmele B, Pluckthun A, Identification of a functional epitope of the Nogo receptor by a combinatorial approach using ribosome display[J].Mol Biol,2005,352(1):229-241.
[66]Andrea B, Huber OW, Christian B, et al. Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesion[J]. Neurosci,2002,22:3553-3567.
[67]Hu F, Liu BP, Budel S, el al. Nogo-A interacts with the Nogo-66 receptor through multiple sites to create an isoform-selective subnanomolar agonist[J]. Neurosci,2005,25(22):5298-5304.
[68]Chen MS, HuberAB, van der HaarME, el al. NogoA is a myelin associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN 21.[J].Nature,2000 (6768),403:434-439.
[69]Oertle T, Huber C, van der Putten H, el al. Genomic structure and functional characterisation of the p romoters of human and mouse Nogo/Rtn24. [J].Mol Biol,2003,325 (2):299-323.
[70]Oertle T, Marjan E. NogoA Inhibits Neurite Outgrowth and Cell Spreading with Three Discrete Regions. Neuroscience,2003,23(13): 5393-5406
[71]Fournier AE, GrandPre T, Strittmatter SM. Identification of a recep tor mediating Nogo-66 inhibition of axonal regeneration. [J].Nature,2001,409 (6818):341-346.
[72]GrandPreT, Li S, Strittmatter SM. Nogo-66 receptor antagonistpep tide p romotes axonal regeneration. Nature,2002,417(6888):547-551.
[73]Li S, Strittmatter SM. Delayed systemic Nogo-66 recep tor antagonist promotes recovery from sp inal cord injury. J Neurosci, 2003,23 (10):4219-4227.
[74]Yamashita T, Tohyama M. The p75 receptor acts as a disp lacement factor that releases Rho from Rho-GD I. Nat Neurosci,2003, 6(5):461-467.
[75]Song XY, Zhong JH, Wang X, el al.Supp ression of p75NTR Does Not Promote Regeneration of Injured Sp inal Cord in Mice. J Neurosci,2004,24(2):542-546.
[76]Zheng B, Atwal J, Ho C, el al. Genetic deletion of the Nogo recep tor does not reduce neurite inhibition in vitro or promote corticosp inal tract regeneration in vivo. PNAS,2005,102(4):1205-1210.
[77]Longa EZ, Weinstein PR, Carlson S el al.Reversible middle cerebral artery occlusion without raniectomy in rats mSoke,1989, 20(1):84-91.
[78]Couet J, Belanger MM, Roussel E, el al.Cell biology of caveolae and caveolin[J]. Adv Drug Deliv Rev,2001,49(3)
[79]远正弥,盐波贞.神经科学尖端技术-分子组织化学[M].北京科学出版社,1995,5.
[80]Horner, P.J,Gage,F.H. Regenerating the damaged central nervous system. Nature,2000,407:963-970
[81]Philippe T. Adult neurogenesis in mammalian central nervous system: functionality and potential clinical interest. Med sci monit,2005,11: RA247-252
[82]Lichtenwalner RJ, Parent JM. Adult neurogenesis and the ischemic forebrain. [J]. Cereb Blood Flow Metab.2006,26(1):1-20.
[83]Arvidsson A,Collin T, Kirik D,el al.Neuronal replacement from endogenous precursors in adult brain after stroke. Nature Med. 2002,8:963-970
[84]Csete M. Oxygen in the cultivation of stem cells. Ann N Y Acad Sci 2005; 1049:1-8
[85]余小骊,谭洁,柴长春,等.补阳还五汤对缺血性脑损伤后成年大鼠海马齿状回神经发生的影响[J].江西中医学院学报,2004,2： 54-56
[86]谭县辉,曲宏达,佟丽,等.补阳还五汤对缺血性脑卒后遗症大鼠神经增殖作用的影响[J].南方医科大学学报,2006,16：189-192
[87]冯玲,孙新芳.补阳还五汤对脑卒中康复的影响[J].中国康复理论与实践,2005,11(6)：465-466
[88]周法根,韦志益,等.黄芪对髓鞘膜蛋白对神经生长抑制的干预作用[J].中国中医药科技,2006,13(3)：161-163
[89]张海宇,马金瑞,等.黄芪注射液对大鼠脑出血灶周围神经元超微结构的影响[J].解剖学杂志,2009,32(3)：295-297
[90]张雅丽,等.黄芪注射液抑制缺氧缺糖后复氧复糖大鼠海马神经细胞凋亡的研究[J].中国老年学杂志,2009,29(7)：793-796
[91]王新生,李海峰,等.黄芪诱导大鼠骨髓间充质干细胞分化早期 胞内钙调蛋白mRNA的转录水平[J].中国组织工程研究与临床康复.2009,23：4495-4499
[92]蒋犁,贾瑞喆,等,黄芪对新生鼠乏氧缺血脑损伤后海马区神经的保护及学习记忆能力的干预[J]中国临床康复,2006,10(7)：154-157
[93]曲友直,赵燕玲,等.黄芪对脑缺血再灌注后神经细胞凋亡及JUN蛋白表达的影响[J]中国中医急症.2007,16(6)：701-702
[94]曲友直,赵燕玲,等.黄芪注射液对脑缺血再灌注后的神经细胞凋亡及相关基因表达的影响[J].神经疾病与精神卫生.2007,7(1)：13-15
[95]韦志益,杨期东,等.黄芪对髓鞘膜蛋白影响神经生长的干预作用和小G蛋白的关系研究[J].中医药学报.2008,2：12-15
[96]石田寅夫,王秀云,等.体外培养胚胎神经干细胞的增殖及中药有效成分对其增殖能力的影响[J].天津中医药,2009,26(2)：155-159
[97]尹艳艳,李卫平,等.芪总苷对大鼠局灶性脑缺血/再灌注损伤后BDNF. TrkB和p75NTR mRNA表达的影响[J].中国药理学通报.2009,25(5)：672-676
[98]凌静.黄芪的临床应用及展望[J].中医药信息,2003,20(3)：121-124.
[99]Dubroff J G, Stevens R T, Hitt J, et al. Anomalous functional organization of barrel cortex in GAP-43 deficient mice[J]. Neurolmage,2006,29:1040-1048.
[100]Ramieri GA, Schierano G, Spada MC, el al. Growth-associated protein 43 immunoreactivity in human oral mucosa in dentate subjects, in edentulous patients and after implant anchored rehabilitation[J]. Clin Oral Implant Res,2004,15(1):66-72.
[101]MIYAKE K, YAMAMOTO W, TADOKORO M, et al. Alterations in hippocampal GAP-43, BDNF, and LI following sustained cerebral ischemia [J]. Brain Res,2002,935 (1-2):24
[102]Navarro X, VivoM, Valero2CabreA. Neural p lasticity after, peripheral nerve injury and regeneration. [J].Prog Neurobiol,2007, 82:163-201.
[103]王红霞,吕国枫,刘晶,等.神经生长相关蛋白GAP-43与精神疾病[J].中国神经精神疾病杂志,2006,32(9)：32-41
[104]管兴志,匡培根.脑缺血后生长相关蛋白43基因表达变化[J].国外医学脑血管疾病分册,2000；8(1)：9
[105]覃华丽,周雪,章为.生长相关蛋白GAP-43的研究现状[J].四川解剖学杂志,2002,10(2)：78-83
[106]Larry IB,Aryeh R1.GAP-43:an intrinsic determinant of neuronal development and plasticity [J].TINS,1997; 20 (2):841
[107]Gerendasy D.Homeostatic tuning of Ca2+ signal transduction by mem2bers of the calpacitin p rotein family[J]. Neurosci Res,1999; 58(1):1071
[108]谭峰,顾卫,等.环维黄杨星D对高血压大鼠脑缺血GAP-43 mRNA表达与细胞损伤的影响[J].中华神经医学杂志,2006,5(10)：989-992
[109]刘光义.大鼠脑缺血再灌注损伤后GAP-43及IGF-1在神经系统中的表达[J].中华神经外科疾病研究杂志,2008,7(3)：223-226
[110]王中琳.缺血性卒中模型大鼠脑内GAP-43的表达及首乌仙海片对其影响[J].中国中医药现代远程教育,2009,7：151-152
[111]霍瑞民,聂亚雄,等.三七总皂苷对大鼠脑出血后肢体功能和MAP-2及GAP-43表达水平的影响[J].中西医结合心脑血管病杂志,2008,6(2)：168-170
[112]张厚兴,梅元武,等.通心络胶囊对局灶性脑缺血大鼠半暗区GAP-43和突触素表达的影响[J].临床急诊杂志,2008,9(134-36
[113]杜秀民,刘红,刘广义.大鼠脑缺血-再灌注损伤后ogo—A及IGF-1的表达和意义[J].中国老年学杂志,2008,28(11)：1061-1063
[114]葛颂,刘雁,宋雪珠等.定量检测神经生长抑制因子及受体在脑梗死大鼠脑组织中的表达[J].中华老年心脑血管杂志,2007,9(9)：626-629
[115]张利军,白宇,侯郁青.[J].中医药导报2008,14(5)：11-14
[116]常丽英,李丹,张苏明等.大鼠脑缺血再灌注后Nogo—A及其受体mRNA和蛋白表达的变化[J].中华神经医学杂志2006,5(9)：870-874
[117]陈涛.Rho/ROCK信号通路与中枢神经轴突再生[J].国际神经病 学神经外科学杂志.2009,6(3)：275-279
[118]蔡光先,杨永华,李跃辉.超微粉体技术与中药饮片改革[J].世界科学技术一中医药现代化,2004,6(2)：67—70
[119]李雅,尹天雷,蔡光先等.补阳还五汤复方超微饮片浸泡液与传统汤剂的化学对比研究[J].中药材2007,30(11)：1459-1461
[120]王爱武.超微粉碎在中药生是中应用概况及展望[J].时珍国医国药,2002,2(7)：669.
[121]陈力.微末中药及其制备技术[J].中草药,2002,33(10)：865-868.
[122]蔡光先,刘柏炎.28味常用中药饮片汤剂与散剂中的用量研究[J].中国实验方剂学杂志,2004,10(2)：63-64.
[123]陈宁,张琪,等.黄芪甲苷在大鼠体内的药代动力学和组织分布研究[J].生物加工过程.2006,8(4)：67-72
[124]吴建宇,李仪奎,符胜光,等.补阳还五汤保护自由基损伤血管内皮细胞的血清药理学实验方法的建立[J].中药药理与临床1999,15(1)：45-46.
[125]底秀敏,李振华,杨琳,等.补阳还五汤药物血清对周围神经再生的影响[J].现代康复,2001,5(12)：58-59.
[126]彭力宏,李翠屏,郑吉民.补阳还五汤含药血清对体外培养大鼠皮层神经元缺氧凋亡的影响[J].广州中医药大学学报,2002,19(3)：207-210.
[127]孙晋浩,杨琳,高英茂,等.灌服中药补阳还五汤的大鼠血清促进胚胎神经上皮细胞存活与分化的研究[J].神经解剖学杂志2003,19(4)：433-437.
[1]金惠铭,王建枝.病理生理学[M].人民卫生出版社,第7版,2008,1：96-109
[2]凌治萍.细胞生物学[M].人民卫生出版社,第1版,2001,9(1)：176-189
[3]Bradshaw RA,Dennis EA.Handbook of cell signaling. Volun 1,2,3. Academic Press.2004
[4]Bustelo XR, Sauzeau V, Berenjeno IM. GTP-binding proteins of the Rho/Rac family regulation, effectors and functions in vivo[J].Bioes-says,2007,29(4):356-370.
[5]Piekny A, Werner M,Glotze M. Cytokinesis:welcome to the Rho zone[J]. Trends Cell Biol,2005,15(12):651-658.
[6]Etienne Manneville S,Hall A. Rho GTPases in cell biology [J]. Nature,2002,420:629-635.
[7]陈涛.Rho/ROCK信号通路与中枢神经轴突再生[J].国际神经病学神经外科学杂志.2009,36(3)：275-279
[8]Teng F Y, TangB L. Why do Nogo/Nogo-66 recep tor gene knockouts result in inferior regeneration compared to treatment with neutralizing agents? [J].Neurochem,2005,94 (4):865-874.
[9]Petratos S, Li QX, George AJ, Hou X, el al. The beta-amyloid protein of Alzheimer's disease increases neuronal CRMP-phosphorylation by a Rho-GTP mechanism [J].Brain.2008 Jan;131(Ptl):90-108.
[10]杜秀民,刘红,刘广义.大鼠脑缺血-再灌注损伤后Nogo—A及IGF-1的表达和意义[J].中国老年学杂志.2008,28(11)：1061-1063
[11]葛颂,刘雁,宋雪珠等.定量检测神经生长抑制因子及受体在脑梗死大鼠脑组织中的表达[J].中华老年心脑血管杂志2007,9(9)：626-629
[12]张利军,白宇,侯郁青.[J].中医药导报2008,14(5)：11-14
[13]常丽英,李丹,张苏明等.大鼠脑缺血再灌注后Nogo—A及其受体mRNA和蛋白表达的变化[J].中华神经医学杂志2006,5(9)：870-874
[14]Andrea B, Huber OW, Christian B, et al. Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesion[J].Neurosci,2002,22:3553-3567.
[15]Hu F, Liu BP, Budel S, et at. Nogo-A interacts with the Nogo-66 receptor through multiple sites to create an isoform-selective subnanomolar agonist[J].Neurosci,2005,25(22):5298-5304.
[16]Chen MS, HuberAB, van der HaarME, el al.NogoA is a myelin associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN 21[J]. Nature,2000(6768),403:4342439.
[17]Oertle T, Huber C, van der Putten H, el al. Genomic structure and functional characterisation of the p romoters of human and mouse Nogo/Rtn24. [J]. Mol Biol,2003,325 (2):2992323.
[18]Oertle T, Marjan E. Nogo-A Inhibits Neurite Outgrowth and Cell Sp reading with Three Discrete Regions[J].Neuroscience,2003,23 (13): 5393 25406.
[19]Fournier AE, GrandPre T, Strittmatter SM. Identification of a recep tor mediating Nogo66 inhibition of axonal regene-ration[J]. Nature,2001,409(6818):341-346.
[20]GrandPreT, Li S, Strittmatter SM. Nogo66 receptor antagonist peptide promotes axonal regeneration[J].Nature,2002,417(6888):547-551.
[21]Li S, Strittmatter SM. Delayed systemic Nogo66 recep tor antagonist promotes recovery from spinal cord injury [J]. Neurosci,2003,23 (10):4219-4227.
[22]Yamashita T, Tohyama M. The p75 recep tor acts as a disp lacement factor that releases Rho from RhoGD I[J]. Nat Neurosci,2003,6(5):461-467.
[23]Song XY, Zhong JH, Wang X, el al. Supp ression of p75NTR Does Not Promote Regeneration of Injured Sp inal Cord in Mice[J]. Neurosci, 2004,24(2):542-546.
[24]Zheng B, Atwal J, Ho C, el al.Genetic deletion of the Nogo recep tor does not reduce neurite inhibition in vitro or p romote corticosp inal tract regeneration in vivo [J].PNAS,2005,102(4):1205-1210.
[25]Da Silva JS, Medina M, Zuliani C, el al.RhoA/ROCK reg ulation of neuritogenesis via profilinIIa mediated control of actin stability [J]. Cell Biol,2003,162(7):67-79.
[26]Arimura N, Inagaki N, Chihara K, el al.Phosphorylation of collapsin response mediator protein 22 by Rho kinase. Evi-dence for two separate signaling pathways for growth cone collapse[J].Biol Chem,2000,275(31):23973-23980
[2]Sacco RL,el al.Vascular disease.In:Merritt's textbook of neurology, 10th edition,2000,217-274
[3]李菁.缺血性脑血管病神经保护治疗的研究进展[J].药物临床治疗杂志,2005,3(6)：16-20.
[4]Taupin P, Gage FH. Adult neurogenesis and neural stem cells of the central nervous system in mammals[J].Neurosci Res,2002,69:745.
[5]Fred H. Gage. Ma mmalian Neural stm cells[J]. Curt opin genet dev, 2003,13(5):543-550.
[6]Albers GW,Hart R,Lutse PHL,et al.Supplement to the guidelines for the management of transient ischemic attacks. [J].Stroke,2000,30: 2502-2511
[7]金惠铭,王建枝.病理生理学[M].人民卫生出版社,第7版,2008,1：271-272
[8]Thrift A G. Cholesterol is associated with stroke, but is not a risk factor[J].Stroke,2004,(35):1524-15257.
[9]Matsuda S, Umeda M, Uchida H, el al.Alterations of oxidative stress markers and apoptosis markers in the striatum after transient focal cerebral ischemia in rats. [J].Neural Transm.2009 Apr,116(4):395-404.
[10]Dowlatshahi D, Hakim A, Fang J, el al.Pre admission antithrombo-tics are associated with improved outcomes following ischaemic stroke:a cohort from the Registry of the Canadian Stroke Network[J].Stroke.2009 Oct;4(5):328-34.
[11]Labarthe DR, Dai S, Fulton JE, el al. Systolic and fourth- and fifth-phase diastolic blood pressure from ages 8 to 18 years:Project HeartBeat! [J]. Prev Med.2009 Jul;37(1 Suppl):S86-96.
[12]Koh-Tan HH, Graham D, Hamilton CA, el al. Renal and vascular glutathioneS-transferase mu is not affected by pharmacological intervention to reduce systolic blood pressure. [J]. Hypertens.2009, Aug;27(8):1575-84.
[13]Kleinig TJ, Kimber TE, Thompson PD. Stroke prevention and stroke thrombolysis:quantifying the potential benefits of best practice therapies[J].Med J Aust.2009, Jun 15,190(12):678-82.
[14]Nakatomi H, Kuriu T, Okabe S, el al. Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. [J].Cell 2002; 110:429-441.
[15]Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke:an integrated view. [J]. Trends Neurosci,1999,22:391-397.
[16]霍玉书,霍虹.鹿茸神经因子活性及促分化作用研究[J].中药新药与临床药理,1997,8(2)：79.
[17]Garofalo L, Silva ABD, Cuello AC.Nerve growth factor-induced synap-togenesis and hypertrophy of cortical cholinergic terminals. Proc Natl A-cad Sci USA,1992,89:2639-2643.
[18]洪新如,陈新民,卢晓欣.不同时间脑室注射脑源性神经营养因子治疗新生大鼠缺氧缺血性脑损伤效果的比较[J].中国药理学通报2002,18(2)：204-207
[19]Veizovic T,Beech JS,Stromer R,et al.Resolution of stroke defi-cits following con-tralateral grafts of conditionally immortal neuroepl-thelial stem cells[J].Stroke.2001,32(4):1012-1019.
[20]Toda H.Takahashi J,lwakami N,et al.Grafting neural stem ceils improved the impaired spatial recognition in ischemic rats[J]. Neu-rosei ett.2001,316(1):9-12.
[21]Aguirre A, Rizvi TA, Ratner N, et al. Over expression ofEGF receptor con-feres migratory properties to non-migratory post natal neural progenitors [J]. Neurosci.2005,25:11092.
[22]Chu K, Kin M, Park KI, et al. Human neural stem cells improve sensorimotor deficits in the adult rat brain with experimental focal ischemia[J].Brain Res,2004,1016:145-153.
[23]唐映红,梁燕,等.补阳还五汤及其有效组分生物碱和苷对动脉血栓形成大鼠抗凝系统活性的影响[J].中国实验方剂学杂志,2007,13(6)：39-42.
[24]曲宏达,佟丽,沈剑刚.等.补阳还五汤对体外培养的大鼠皮层神经 元缺氧凋亡的影响[J].第一军医大学学报,2002,22(1)：35-38.
[25]宋含平,刘志龙,邓常青.补阳还五汤对沙鼠脑缺血后海马CA1区细胞形态结构与细胞凋亡的影响[J].中国中医药信息杂志,2004,8：682.
[26]唐映红,李花,等.补阳还五汤有效部位对局灶性脑缺血再灌注后caspase表达的作用[J].中国中西医结合杂志.2006,26(6)：533-537
[27]蔡光先,刘柏炎.阳还五汤对体外低糖低氧损伤海马神经干细胞增殖的影响[J].湖南中医学院学报,2005,25(2)：1-3
[28]刘柏炎,蔡光先,等.补阳还五汤对大鼠局灶性脑缺血后神经干细胞影响的初步研究[J].中国临床康复.2004,8(22)：4532-4533
[29]刘柏炎,蔡光先,等.补阳还五汤对低糖低氧损伤神经干细胞移行分化的影响[J],中国药物与临床.2005,5(3)：171-173
[30]张运克,车志英.益气活血方体外诱导大鼠骨髓间充质干细胞向神经细胞的分化[J].中国组织工程研究与临床康复,2009,13(6)：1171-1175
[31]刘芳,白雪松,刘柏炎,等.补阳还五汤对脑缺血大鼠碱性成纤维细胞生长因子的影响[J],中国中西医结合急救杂志.2008,15(1)：9-12
[32]尹天雷,蔡光先,等.补阳还五汤对脑缺血模型大鼠脑组织NGF及P13 K/AKT信号转导途径的影响[J].中国中医药科技.2008,15(1)：24-25
[33]刘柏炎,沈剑刚,蔡光先,等.补阳还五汤对局灶性脑缺血大鼠脑内caveolinl.2的影响[J].湖南中医药大学学报,2008,28(1)：22-28
[34]Chen Y, Sun FY. Age-related decrease of striatal neurogenesis is associated with apoptosis of neural precursors and newborn neurons in rat brain after ischemia. [J].Brain Res.2007 Jul 7;
[35]Gold B G. FK506 and the role of the immunophilin FKBP-52 in nerve regeneration [J].Drug Mestabol Rev.1999,31:649-663.
[36]Wang M S, Gold B G.FK506 increases the regeneration of spinal cord axons in a predegenerated peripheral nerve autograft [J].Spinal Cord Med.1999,22(4):287-296.
[37]Lee M. Doolabh V B. Mackinnen S E. et al FK506 promotes functional reeovery in crushed rat sciatic nerve Muscle [J].Nerve. 2000.23(4):633-640.
[38]崔瑾等.急性脑缺血大鼠海马和齿状回神经元β-NGF与NGFRs基因表达变化对其生存影响的研究[J].现代神经疾病杂志2003,3(3)：137-141
[39]田京发,刘达根,付小兵.碱性成纤维细胞生长因子的药代动力学研究进展[J].中国危重病急救医学,2000,12(8)：509—510
[40]Yao H, Takasawa R, Fukuda K, et al. DNA fragmentation in ischemic core and penumbra in focal cerebral ischemia in rats. [J].Brain Res gol Brain Res 2001; 91(1-2):112-118.
[41]Rao RV, Hermel E, Castro Obregon S, et al. Coupling end—plasmic reticulum stress to the cell death program. Mechanism of caspase activation. [J]. Biol Chem 2001; 276(36):33869-33874.
[42]McManus Jp, Buchan AM. Apoptosis after experimental stroke: faCt or fashion? [J].Neurotrauma 2000,17(10):899-914.
[43]Davoli MA, Fourtounis J, Tam J, el al.Immunohistochemical and biochemical assessment of caspase 3 activation andDNA fragmenta-tion following transient focal ischemia in the rat[J].Neuroscience 2002,115(1):125-136.
[44]韩彩萍.PI3K/AKT信号通路与脑缺血神经细胞凋亡[J].国际神经病学神经外科学杂志,2006,33(1)
[45]曲鹏等.凋亡相关基因与脑缺血再灌注损伤[J].解剖科学进展,2006,12(1)：52-56
[46]汪咏莳,周国民.中枢神经系统microRNA的研究进展[J].解剖学杂志.2009,32(3)：410-412
[47][J].生物学教学,2009,34(4)：76
[48]Nadeau S, Hein P, Fernandes K J, et al. A transcrip tional role for C/EBP beta in the neuronal response to axonal injury [J]. Mol CellNeu2rosci,2005,29 (4):525-535.
[49]Becker T, Lieberoth B C, Becker C G, et al. Differences in the regen-erative response of neuronal cell populations and indications for p lasticity in intrasp inal neurons after sp inal cord transection in adult zebrafish [J]. Mol Cell Neurosci,2005,30 (2):265-278.
[50]Li Y, Chen J, Zhang C L, et al. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells [J].Glia, 2005,49(3):407-417.
[51]Ollom CM, Denny JB. A Crosslinking Analysis of GAP-43 Interactions with Other Proteins in Differentiated N1E-115 Cells. [J].Mol Sci.2008,9(9):1753-71.
[52]Nguyen L, He Q, Meiri KF. Regulation of GAP-43 at serine 41 acts as a switch to modulate both intrinsic and extrinsic. behaviors of growing neurons, via altered membrane distribution. [J]. Mol Cell Neurosci.2009 May; 41(1):62-73.
[53]严恒林.生长相关蛋白(GAP-43)与神经发育和再生[J].神经解剖学杂志,1993,9(2)：1551
[54]Ludwig A, Silvia A, Josef PK, el al.Overexp ression of the neural growth-associated protein GAP-43 induces nerve sp routing in the adult nervoussystem of transgenic mice[J].Cell,1995; 83:2691
[55]吕刚等.神经干细胞分化过程中GAP-43基因的表达及其意义[J].中国医科大学学报.2007,36(1)：47-48
[56]赵惠等.8溴-环磷酸腺苷对脑缺血再灌注大鼠PKA及GAP-43蛋白表达的影响[J].脑与神经疾病杂志.2007,15(2)：101-103
[57]Luque JM, Puign N,Martinez JM, el al.Glutamate Nmethy LDaspar- tate recep tor blockade prevents induction of GAP-43 after focal ischemiain rats[J].1Neurosci Lett,2001; 305 (2):87-91
[58]Bustelo XR, Sauzeau V, Berenjeno IM. GTP-binding p roteins of the Rho/Rac family:regulation,effectors and functions in vivo. [J].Bioessays,2007,29(4):356-370
[59]Piekny A, Werner M,Glotze M. Cytokinesis:welcome to the Rho zone [J]. Trends Cell Biol,2005,15 (12):651-658.
[60]Etienne2Manneville S,Hall A. Rho GTPases in cell biology[J]. Nature,2002,420:629-635.
[61]Teng F Y, TangB L. Why do Nogo/Nogo-66 recep tor gene knockouts result in inferior regeneration compared to treatment with neutralizing agents? [J].J Neurochem,2005,94 (4):865-874.
[62]Petratos S, Li QX, George AJ, el al. The beta-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism. [J].Brain.2008 Jan;131(Pt 1):90-108.
[63]陈胜利,李长清.RhoA与神经轴突的生长[J].实用神经疾病杂.2005,8(3)：36-37
[64]李德渊,陈娟,等.脑白质损伤新生大鼠脑白质P75NTR蛋白与RhoA mRNA的表达及意义[J].中国当代儿科杂志.2007,9(4)：317-320
[65]Schimmele B, Pluckthun A, Identification of a functional epitope of the Nogo receptor by a combinatorial approach using ribosome display[J].Mol Biol,2005,352(1):229-241.
[66]Andrea B, Huber OW, Christian B, et al. Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesion[J]. Neurosci,2002,22:3553-3567.
[67]Hu F, Liu BP, Budel S, el al. Nogo-A interacts with the Nogo-66 receptor through multiple sites to create an isoform-selective subnanomolar agonist[J]. Neurosci,2005,25(22):5298-5304.
[68]Chen MS, HuberAB, van der HaarME, el al. NogoA is a myelin associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN 21.[J].Nature,2000 (6768),403:434-439.
[69]Oertle T, Huber C, van der Putten H, el al. Genomic structure and functional characterisation of the p romoters of human and mouse Nogo/Rtn24. [J].Mol Biol,2003,325 (2):299-323.
[70]Oertle T, Marjan E. NogoA Inhibits Neurite Outgrowth and Cell Spreading with Three Discrete Regions. Neuroscience,2003,23(13): 5393-5406
[71]Fournier AE, GrandPre T, Strittmatter SM. Identification of a recep tor mediating Nogo-66 inhibition of axonal regeneration. [J].Nature,2001,409 (6818):341-346.
[72]GrandPreT, Li S, Strittmatter SM. Nogo-66 receptor antagonistpep tide p romotes axonal regeneration. Nature,2002,417(6888):547-551.
[73]Li S, Strittmatter SM. Delayed systemic Nogo-66 recep tor antagonist promotes recovery from sp inal cord injury. J Neurosci, 2003,23 (10):4219-4227.
[74]Yamashita T, Tohyama M. The p75 receptor acts as a disp lacement factor that releases Rho from Rho-GD I. Nat Neurosci,2003, 6(5):461-467.
[75]Song XY, Zhong JH, Wang X, el al.Supp ression of p75NTR Does Not Promote Regeneration of Injured Sp inal Cord in Mice. J Neurosci,2004,24(2):542-546.
[76]Zheng B, Atwal J, Ho C, el al. Genetic deletion of the Nogo recep tor does not reduce neurite inhibition in vitro or promote corticosp inal tract regeneration in vivo. PNAS,2005,102(4):1205-1210.
[77]Longa EZ, Weinstein PR, Carlson S el al.Reversible middle cerebral artery occlusion without raniectomy in rats mSoke,1989, 20(1):84-91.
[78]Couet J, Belanger MM, Roussel E, el al.Cell biology of caveolae and caveolin[J]. Adv Drug Deliv Rev,2001,49(3)
[79]远正弥,盐波贞.神经科学尖端技术-分子组织化学[M].北京科学出版社,1995,5.
[80]Horner, P.J,Gage,F.H. Regenerating the damaged central nervous system. Nature,2000,407:963-970
[81]Philippe T. Adult neurogenesis in mammalian central nervous system: functionality and potential clinical interest. Med sci monit,2005,11: RA247-252
[82]Lichtenwalner RJ, Parent JM. Adult neurogenesis and the ischemic forebrain. [J]. Cereb Blood Flow Metab.2006,26(1):1-20.
[83]Arvidsson A,Collin T, Kirik D,el al.Neuronal replacement from endogenous precursors in adult brain after stroke. Nature Med. 2002,8:963-970
[84]Csete M. Oxygen in the cultivation of stem cells. Ann N Y Acad Sci 2005; 1049:1-8
[85]余小骊,谭洁,柴长春,等.补阳还五汤对缺血性脑损伤后成年大鼠海马齿状回神经发生的影响[J].江西中医学院学报,2004,2： 54-56
[86]谭县辉,曲宏达,佟丽,等.补阳还五汤对缺血性脑卒后遗症大鼠神经增殖作用的影响[J].南方医科大学学报,2006,16：189-192
[87]冯玲,孙新芳.补阳还五汤对脑卒中康复的影响[J].中国康复理论与实践,2005,11(6)：465-466
[88]周法根,韦志益,等.黄芪对髓鞘膜蛋白对神经生长抑制的干预作用[J].中国中医药科技,2006,13(3)：161-163
[89]张海宇,马金瑞,等.黄芪注射液对大鼠脑出血灶周围神经元超微结构的影响[J].解剖学杂志,2009,32(3)：295-297
[90]张雅丽,等.黄芪注射液抑制缺氧缺糖后复氧复糖大鼠海马神经细胞凋亡的研究[J].中国老年学杂志,2009,29(7)：793-796
[91]王新生,李海峰,等.黄芪诱导大鼠骨髓间充质干细胞分化早期 胞内钙调蛋白mRNA的转录水平[J].中国组织工程研究与临床康复.2009,23：4495-4499
[92]蒋犁,贾瑞喆,等,黄芪对新生鼠乏氧缺血脑损伤后海马区神经的保护及学习记忆能力的干预[J]中国临床康复,2006,10(7)：154-157
[93]曲友直,赵燕玲,等.黄芪对脑缺血再灌注后神经细胞凋亡及JUN蛋白表达的影响[J]中国中医急症.2007,16(6)：701-702
[94]曲友直,赵燕玲,等.黄芪注射液对脑缺血再灌注后的神经细胞凋亡及相关基因表达的影响[J].神经疾病与精神卫生.2007,7(1)：13-15
[95]韦志益,杨期东,等.黄芪对髓鞘膜蛋白影响神经生长的干预作用和小G蛋白的关系研究[J].中医药学报.2008,2：12-15
[96]石田寅夫,王秀云,等.体外培养胚胎神经干细胞的增殖及中药有效成分对其增殖能力的影响[J].天津中医药,2009,26(2)：155-159
[97]尹艳艳,李卫平,等.芪总苷对大鼠局灶性脑缺血/再灌注损伤后BDNF. TrkB和p75NTR mRNA表达的影响[J].中国药理学通报.2009,25(5)：672-676
[98]凌静.黄芪的临床应用及展望[J].中医药信息,2003,20(3)：121-124.
[99]Dubroff J G, Stevens R T, Hitt J, et al. Anomalous functional organization of barrel cortex in GAP-43 deficient mice[J]. Neurolmage,2006,29:1040-1048.
[100]Ramieri GA, Schierano G, Spada MC, el al. Growth-associated protein 43 immunoreactivity in human oral mucosa in dentate subjects, in edentulous patients and after implant anchored rehabilitation[J]. Clin Oral Implant Res,2004,15(1):66-72.
[101]MIYAKE K, YAMAMOTO W, TADOKORO M, et al. Alterations in hippocampal GAP-43, BDNF, and LI following sustained cerebral ischemia [J]. Brain Res,2002,935 (1-2):24
[102]Navarro X, VivoM, Valero2CabreA. Neural p lasticity after, peripheral nerve injury and regeneration. [J].Prog Neurobiol,2007, 82:163-201.
[103]王红霞,吕国枫,刘晶,等.神经生长相关蛋白GAP-43与精神疾病[J].中国神经精神疾病杂志,2006,32(9)：32-41
[104]管兴志,匡培根.脑缺血后生长相关蛋白43基因表达变化[J].国外医学脑血管疾病分册,2000；8(1)：9
[105]覃华丽,周雪,章为.生长相关蛋白GAP-43的研究现状[J].四川解剖学杂志,2002,10(2)：78-83
[106]Larry IB,Aryeh R1.GAP-43:an intrinsic determinant of neuronal development and plasticity [J].TINS,1997; 20 (2):841
[107]Gerendasy D.Homeostatic tuning of Ca2+ signal transduction by mem2bers of the calpacitin p rotein family[J]. Neurosci Res,1999; 58(1):1071
[108]谭峰,顾卫,等.环维黄杨星D对高血压大鼠脑缺血GAP-43 mRNA表达与细胞损伤的影响[J].中华神经医学杂志,2006,5(10)：989-992
[109]刘光义.大鼠脑缺血再灌注损伤后GAP-43及IGF-1在神经系统中的表达[J].中华神经外科疾病研究杂志,2008,7(3)：223-226
[110]王中琳.缺血性卒中模型大鼠脑内GAP-43的表达及首乌仙海片对其影响[J].中国中医药现代远程教育,2009,7：151-152
[111]霍瑞民,聂亚雄,等.三七总皂苷对大鼠脑出血后肢体功能和MAP-2及GAP-43表达水平的影响[J].中西医结合心脑血管病杂志,2008,6(2)：168-170
[112]张厚兴,梅元武,等.通心络胶囊对局灶性脑缺血大鼠半暗区GAP-43和突触素表达的影响[J].临床急诊杂志,2008,9(134-36
[113]杜秀民,刘红,刘广义.大鼠脑缺血-再灌注损伤后ogo—A及IGF-1的表达和意义[J].中国老年学杂志,2008,28(11)：1061-1063
[114]葛颂,刘雁,宋雪珠等.定量检测神经生长抑制因子及受体在脑梗死大鼠脑组织中的表达[J].中华老年心脑血管杂志,2007,9(9)：626-629
[115]张利军,白宇,侯郁青.[J].中医药导报2008,14(5)：11-14
[116]常丽英,李丹,张苏明等.大鼠脑缺血再灌注后Nogo—A及其受体mRNA和蛋白表达的变化[J].中华神经医学杂志2006,5(9)：870-874
[117]陈涛.Rho/ROCK信号通路与中枢神经轴突再生[J].国际神经病 学神经外科学杂志.2009,6(3)：275-279
[118]蔡光先,杨永华,李跃辉.超微粉体技术与中药饮片改革[J].世界科学技术一中医药现代化,2004,6(2)：67—70
[119]李雅,尹天雷,蔡光先等.补阳还五汤复方超微饮片浸泡液与传统汤剂的化学对比研究[J].中药材2007,30(11)：1459-1461
[120]王爱武.超微粉碎在中药生是中应用概况及展望[J].时珍国医国药,2002,2(7)：669.
[121]陈力.微末中药及其制备技术[J].中草药,2002,33(10)：865-868.
[122]蔡光先,刘柏炎.28味常用中药饮片汤剂与散剂中的用量研究[J].中国实验方剂学杂志,2004,10(2)：63-64.
[123]陈宁,张琪,等.黄芪甲苷在大鼠体内的药代动力学和组织分布研究[J].生物加工过程.2006,8(4)：67-72
[124]吴建宇,李仪奎,符胜光,等.补阳还五汤保护自由基损伤血管内皮细胞的血清药理学实验方法的建立[J].中药药理与临床1999,15(1)：45-46.
[125]底秀敏,李振华,杨琳,等.补阳还五汤药物血清对周围神经再生的影响[J].现代康复,2001,5(12)：58-59.
[126]彭力宏,李翠屏,郑吉民.补阳还五汤含药血清对体外培养大鼠皮层神经元缺氧凋亡的影响[J].广州中医药大学学报,2002,19(3)：207-210.
[127]孙晋浩,杨琳,高英茂,等.灌服中药补阳还五汤的大鼠血清促进胚胎神经上皮细胞存活与分化的研究[J].神经解剖学杂志2003,19(4)：433-437.
[1]金惠铭,王建枝.病理生理学[M].人民卫生出版社,第7版,2008,1：96-109
[2]凌治萍.细胞生物学[M].人民卫生出版社,第1版,2001,9(1)：176-189
[3]Bradshaw RA,Dennis EA.Handbook of cell signaling. Volun 1,2,3. Academic Press.2004
[4]Bustelo XR, Sauzeau V, Berenjeno IM. GTP-binding proteins of the Rho/Rac family regulation, effectors and functions in vivo[J].Bioes-says,2007,29(4):356-370.
[5]Piekny A, Werner M,Glotze M. Cytokinesis:welcome to the Rho zone[J]. Trends Cell Biol,2005,15(12):651-658.
[6]Etienne Manneville S,Hall A. Rho GTPases in cell biology [J]. Nature,2002,420:629-635.
[7]陈涛.Rho/ROCK信号通路与中枢神经轴突再生[J].国际神经病学神经外科学杂志.2009,36(3)：275-279
[8]Teng F Y, TangB L. Why do Nogo/Nogo-66 recep tor gene knockouts result in inferior regeneration compared to treatment with neutralizing agents? [J].Neurochem,2005,94 (4):865-874.
[9]Petratos S, Li QX, George AJ, Hou X, el al. The beta-amyloid protein of Alzheimer's disease increases neuronal CRMP-phosphorylation by a Rho-GTP mechanism [J].Brain.2008 Jan;131(Ptl):90-108.
[10]杜秀民,刘红,刘广义.大鼠脑缺血-再灌注损伤后Nogo—A及IGF-1的表达和意义[J].中国老年学杂志.2008,28(11)：1061-1063
[11]葛颂,刘雁,宋雪珠等.定量检测神经生长抑制因子及受体在脑梗死大鼠脑组织中的表达[J].中华老年心脑血管杂志2007,9(9)：626-629
[12]张利军,白宇,侯郁青.[J].中医药导报2008,14(5)：11-14
[13]常丽英,李丹,张苏明等.大鼠脑缺血再灌注后Nogo—A及其受体mRNA和蛋白表达的变化[J].中华神经医学杂志2006,5(9)：870-874
[14]Andrea B, Huber OW, Christian B, et al. Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesion[J].Neurosci,2002,22:3553-3567.
[15]Hu F, Liu BP, Budel S, et at. Nogo-A interacts with the Nogo-66 receptor through multiple sites to create an isoform-selective subnanomolar agonist[J].Neurosci,2005,25(22):5298-5304.
[16]Chen MS, HuberAB, van der HaarME, el al.NogoA is a myelin associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN 21[J]. Nature,2000(6768),403:4342439.
[17]Oertle T, Huber C, van der Putten H, el al. Genomic structure and functional characterisation of the p romoters of human and mouse Nogo/Rtn24. [J]. Mol Biol,2003,325 (2):2992323.
[18]Oertle T, Marjan E. Nogo-A Inhibits Neurite Outgrowth and Cell Sp reading with Three Discrete Regions[J].Neuroscience,2003,23 (13): 5393 25406.
[19]Fournier AE, GrandPre T, Strittmatter SM. Identification of a recep tor mediating Nogo66 inhibition of axonal regene-ration[J]. Nature,2001,409(6818):341-346.
[20]GrandPreT, Li S, Strittmatter SM. Nogo66 receptor antagonist peptide promotes axonal regeneration[J].Nature,2002,417(6888):547-551.
[21]Li S, Strittmatter SM. Delayed systemic Nogo66 recep tor antagonist promotes recovery from spinal cord injury [J]. Neurosci,2003,23 (10):4219-4227.
[22]Yamashita T, Tohyama M. The p75 recep tor acts as a disp lacement factor that releases Rho from RhoGD I[J]. Nat Neurosci,2003,6(5):461-467.
[23]Song XY, Zhong JH, Wang X, el al. Supp ression of p75NTR Does Not Promote Regeneration of Injured Sp inal Cord in Mice[J]. Neurosci, 2004,24(2):542-546.
[24]Zheng B, Atwal J, Ho C, el al.Genetic deletion of the Nogo recep tor does not reduce neurite inhibition in vitro or p romote corticosp inal tract regeneration in vivo [J].PNAS,2005,102(4):1205-1210.
[25]Da Silva JS, Medina M, Zuliani C, el al.RhoA/ROCK reg ulation of neuritogenesis via profilinIIa mediated control of actin stability [J]. Cell Biol,2003,162(7):67-79.
[26]Arimura N, Inagaki N, Chihara K, el al.Phosphorylation of collapsin response mediator protein 22 by Rho kinase. Evi-dence for two separate signaling pathways for growth cone collapse[J].Biol Chem,2000,275(31):23973-23980